​

Funding Round

Series B - Memo Therapeutics

Series B - Memo Therapeutics

Investment Firm

Overview

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

Announced Date

Feb 16, 2022

Closed on Date

Feb 16, 2022

Funding Type

Series B

Highlights

Location

Switzerland, Europe

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorZürcher Kantonal Bank
Participant InvestorVesalius Biocapital Partners
Participant InvestorSwisscanto Private Equity
Participant InvestorFresenius Medical Care
Participant InvestorVerve Ventures

Round Details and Background

Memo Therapeutics raised $24947366 on 2022-02-16 in Series B

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 16, 2022
Series B - Memo Therapeutics
8-24.9M
Nov 02, 2023
Series C - Memo Therapeutics
9-27.6M
May 07, 2024
Series C - Memo Therapeutics
2-22.0M
Jul 22, 2015
Series A - Memo Therapeutics
3-2.3M

Recent Activity

There is no recent news or activity for this profile.